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Abstract 
Aspartame, methyl-L-α-aspartyl-L-phenylalaninate, is used worldwide as a sweetener in 
foods and drinks and is considered to be safe at an acceptable daily intake (ADI) of 40 
mg per kg of body weight. This compound is completely hydrolyzed in the gastrointestinal 
tract to aspartic acid, phenylalanine and methanol, each being toxic at high levels. The 
objective of the present study was to quantify the volatile methanol component in the exhaled 
breath of ten healthy volunteers following the ingestion of a single ADI dose of aspartame. 
Direct on-line measurements of methanol concentration were made in the mouth and nose 
breath exhalations using selected ion flow tube mass spectrometry, SIFT-MS, several times 
before aspartame ingestion in order to establish individual pre-dose (baseline) levels and then 
during two hours post-ingestion to track their initial increase and subsequent decrease. The 
results show that breath methanol concentrations increased in all volunteers by 1082 ±205 
parts-per-billion by volume, ppbv, from their pre-ingestion values, which ranged from 193 to 
436 parts-per-billion by volume, ppbv, to peak values ranging from 981-1622 ppbv, from 
which they slowly decreased. These observations agree quantitatively with a predicted 
increase of 1030 ppbv estimated using a one-compartment model of uniform dilution of the 
methanol generated from a known amount of aspartame throughout the total body water 
(including blood). In summary, an ADI dose of aspartame leads to a 3 – 6 fold increase of 
blood methanol concentration above the individual baseline values. 
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1. Introduction 
Quantitative analysis of exhaled breath for volatile trace compounds is providing a non-
invasive window into physiological and pathophysiological processes, revealing volatile 
biomarkers of particular diseases and infections, allowing the biochemistry and metabolism 
of ingested foods and drugs to be traced, and the uptake into the blood stream of ambient 
toxic compounds to be monitored. All this represents a valuable contribution to medical 
diagnosis and therapeutic monitoring, the history and development of which are reported in 
two texts co-edited by Anton Amann [1, 2]. The research work reported in this paper, which 
quantitatively connects breath methanol with ingested aspartame, is homage to our dear 
friend and colleague, Anton, in recognition of his pioneering work and enormous 
contributions to breath analysis, which have laid the foundations to this new area of research. 
Aspartame, methyl-L-α-aspartyl-L-phenylalaninate, is marketed under several brand names 
and is widely used as a sweetener additive in cakes, candies and fizzy drinks such as cola [3]. 
It has been studied widely because of its potential toxicity since it is hydrolyzed in the 
stomach and in the small intestine to aspartic acid, phenylalanine and methanol. Currently, 
the acceptable daily intake (ADI) of aspartame in Europe is 40 mg per kg of body weight 
(simplified to mg/kg in what follows) and in the United States is 50 mg/kg [4]. Although it 
has been declared safe at ADI or lower doses [5, 6], connection has been suggested to a wide 
range of adverse conditions and diseases, including lymphomas and leukemia [7]. The 
aspartic acid component is connected to neurological disorders including migraine, seizures, 
epilepsy [8]. Aspartame should not be ingested by suffers from phenylketonuria since it will 
exacerbate the condition. The methanol product is converted by metabolism to formaldehyde 
[4, 9]. It has been suggested that formaldehyde binds to tissue proteins and nucleic acids and 
this is cumulative; thus, it can represent a hazard to health [9]. Finally, formaldehyde is 
converted to formic acid that has a longer half-life in the body and is considered to be the 
primary toxic compound in methanol poisoning [4]. 
The amount of methanol produced from the average amounts of aspartame in a normal diet 
(estimated as 8 mg/kg by the FDA [4, 10] ) has been observed to result in some rise in blood 
methanol concentration, but this increase was comparable with the intra-individual 
differences of endogenous methanol [10]. It is not certain if this amount of methanol is of any 
concern since it is comparable to its generation from ingested fruit juices, citrus fruits and 
fermented beverages [11]. However, it was reported that methanol is clearly elevated in blood 
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following ingestion of typically 100 mg/kg doses of aspartame (more than twice ADI). In a 
1981 study [12], blood methanol remained below the detection limit (of the analytical 
technique used) of subjects who ingested 34 mg/kg, but elevation was observed at abuse 
doses of 100 to 200 mg/kg. Blood analyses were carried out in 6 subjects who ingested 
aspartame at 200 mg/kg but, no significant increases in blood formate concentration were 
noted [12]. In a subsequent 1989 study in which six adults ingested four servings of beverage 
each containing 600 mg of aspartame over several hours, equivalent to a typical ADI, blood 
methanol and formate concentrations remained below the limit of detection of the techniques 
used [13].  
Methanol, unlike phenylalanine and aspartic acid, is a very volatile compound that was first 
detected in exhaled breath more than 50 years ago [14]. It is present in exhaled breath of all 
human beings [15-17], as is formaldehyde at much lower concentrations [18, 19]. Formic 
acid is presumably present in breath also, but there are practical reasons why it is difficult to 
detect and quantify by selected ion flow tube mass spectrometry (SIFT-MS) and proton 
transfer reaction mass spectrometry (PTR-MS) [20]. Previous SIFT-MS studies of exhaled 
breath methanol in the general population have shown that concentrations range widely from 
32 parts-per-billion by volume, ppbv, to 2319 ppbv [21], with a median value in ppbv 
reported in specific studies to be 461 [22], 238 [23], 193 [24] and 189 [18]. Later SIFT-MS 
studies of mouth-exhaled and nose-exhaled breath have shown that the methanol is largely 
systemic, i.e. it is generated endogenously, being present in the blood stream with little, if 
any, generated in the oral cavity [19]. These previous results will be referred to again later 
and compared with those obtained in the present study. The origin of endogenous methanol is 
usually considered to be by the action of gut bacteria on carbohydrates and sugars with a 
contribution from the breakdown of ingested aspartame to be expected. The aim of the 
present study was to quantify, for the first time, the increase of methanol in exhaled breath 
following an acceptable daily intake (ADI) of aspartame as set by the European Food Safety 
Authority [25].  
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2. Materials and methods 
The objective of the study was to establish how the concentration of breath methanol changes 
after ingestion of an ADI of aspartame by a group of healthy volunteers. 
2.1. Volunteers 
10 healthy volunteers were recruited to the study that was carried out .at the J. Heyrovsky 
Institute of Physical Chemistry in Prague. The biometrics of the individuals in the group are 
given in Table 1. Ethical permission for the study was obtained from the Ethics Committee of 
the Science Faculty of Charles University in Prague. All participants were informed of the 
protocol of the study and each provided informed consent before participating. Exclusion 
criteria were that volunteers did not suffer from diabetes or phenylketonuria.  
2.2. Aspartame dose. 
The toxicity of aspartame has been thoroughly investigated in animal models and it has been 
shown that chronic toxicity results at ingestion concentrations of 4000 mg/kg. From the 
collected data it was concluded that at the currently established ADI of 40 mg/kg there are no 
safety concerns [25]. Thus, the volunteers were requested to ingest an amount of aspartame at 
the safe ADI level as contained in “Irbis sweet” (manufactured by Irbis s.r.o., Slusovice, 
Czech Republic). This sweetener contains 19.5% of aspartame together with lactose (major 
ingredient), croscarmellose and L-leucine. The ingested aspartame dose was prepared as an 
appropriate number of “Irbis sweet” tablets dissolved in 200 mL of tap water at a temperature 
of 15 °C. 
2.3. SIFT-MS analyses of exhaled breath methanol using SIFT-MS 
The selected ion flow tube mass spectrometry (SIFT-MS) technique has been described in 
detail in several review papers and need not be repeated in depth here [26-28]. The strengths 
and weaknesses of this analytical technique has been discussed recently [29] and the pitfalls 
in the approaches to breath analysis in general are reviewed in a very recent paper in the 
Journal of Breath Research [21]. It is sufficient to say that SIFT-MS analysis involve the 
chemical ionization by chosen reagent ions (H3O+, NO+, O2+) of the trace compounds in a 
breath sample that has been introduced directly into a reactor flow tube. Characteristic 
analyte ions are produced in the reactions of the reagent ions and the trace neutral analyte 
molecules in the breath sample and from an in-depth knowledge of this ion chemistry, both 
the identity of the analyte molecules and, most importantly, their accurate quantification can 
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be achieved even in single breath exhalations. It has been shown many times that detection 
and quantification of methanol in exhaled breath using H3O+ reagent ions is straightforward 
as long as the common analyte ion of the ever-present isoprene in the breath sample at mass-
to-charge ratio, m/z, at 69 is excluded from the analysis. These details of methanol analysis 
have been discussed thoroughly in a recent paper [30]. It is sufficient to note that analysis is 
performed using the H3O+ reagent ion (mass-to-charge ratio, m/z 19) and its hydrates at m/z 
37, 55 and 73, and the analyte ions used for methanol analysis are only CH3OH2+ (m/z 33) 
and its monohydrate CH3OH2+H2O (m/z 51) .  
The usual approach to breath analysis, when directed towards intervention and 
pharmacokinetics studies involving ingestion of medicines, therapeutic drugs, isotopically 
labelled tracers and alcoholic beverages, is first to establish the pre-dose breath 
concentrations of the targeted volatile compounds to establish the “baseline value” for each 
of the 10 individuals involved. Thus, in the present study the methanol concentration in the 
exhaled breath of each of the 10 volunteers was determined in three consecutive single 
exhalations/inhalations every 15 minutes over one hour before aspartame ingestion. The 
following breath sampling procedure was used in the present study:  
Each volunteer exhaled and inhaled three times consecutively via a disposable cardboard 
mouthpiece inserted into the SIFT-MS breath sampling adaptor fitted with a flow restricting 
aperture (4.8 mm diameter, 4 mm long). Exhalations and inhalations were of 10 to 15 s 
durations. Volunteers were standing during the sampling and avoided any unusual physical 
activity prior to and during the study. A fraction of the air/breath is sampled from the 
midstream via a short calibrated capillary and flows through a longer PEEK line and an inlet 
port into the helium carrier gas of the SIFT-MS instrument for analysis. The entire sampling 
line is heated to minimise loss of condensable compounds, including methanol and water 
vapour. The capillary establishes the breath/air sample flow rate at a known value 
(24 mL/min in the present experiments), as is essential for accurate metabolite quantification 
[30, 31]. Analysis is performed using the multiple ion monitoring (MIM) mode of SIFT-MS 
[31]; for methanol, the analyte ions given above are targeted. The water vapour concentration 
was routinely measured, as is the recommended practice in the SIFT-MS breath studies [30, 
31], which acts as a check of the correct air/breath sampling rate. Thus, the water vapour 
must be > 5% by volume of exhaled breath [30-32]. The last two thirds of each individual 
exhalation concentration time profile, as identified by the water vapour concentration profile, 
were selected for the methanol concentration measurement. This sampling procedure was 
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repeated following the ingestion of the aspartame at the individual dosage of 40 mg/kg of 
body weight, extending the observation time to 2 hours post-ingestion. The average values of 
the methanol concentrations from the three consecutive exhalations were calculated and 
tabulated for each volunteer, as were the ambient air methanol concentrations (from 
inhalations). In addition to mouth exhalations, nose-exhaled concentrations were determined 
in a similar fashion for volunteers 1 to 4.  
 
3. Results 
 
Figure 1 Time profiles of mouth-exhaled methanol concentration in parts-
per-billion by volume, ppbv, for four volunteers (1 - ♦, 2 - ●, 3 - , 4 - ▲) 
before (P) and after ingestion of the aspartame dose at the time indicated by 
the vertical arrow. The peak post-ingestion (M) mouth-exhaled breath 
methanol concentrations are indicated by arrows. 
The background methanol concentration in the inhaled air during these studies was in the 
range 50 to 100 ppbv. Its contribution to the exhaled breath concentration can be determined 
using the retention coefficient of 0.29 for methanol, as determined in a recent SIFT-MS study 
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[33] and is estimated to be  less than 30 ppbv in the exhaled breath, so it was not necessary to 
correct the data for this. Sample data for the mouth-exhaled methanol concentrations are 
shown in Figure 1 for volunteers No. 1 – 4 (see Table 1) spanning the time period from the 
first pre-dose measurements to the last post-dose measurements. The concentration-time 
profiles for all ten volunteers had similar shapes as those given in Figure 1, but all are not 
shown for clarity. The time taken for the breath methanol to reach its peak for all ten 
individuals varied from about 15 to 30 minutes post-ingestion after which it begins to 
decrease. Interpretation of these trends will be presented in the Discussion section. 
The pre-ingestion (P) and the peak post-ingestion (M) mean mouth-exhaled breath methanol 
concentrations in ppbv are given in Table 1 together with their differences (M-P) that 
correspond to the maximum increases due to the aspartame ingestion. Also given are the 
uncertainties in all measurements as determined from the standard error calculated from 
variation between all data points recorded during the three exhalations [31]. The intra-
individual variation observed prior to ingestion was in the range of S.D. 12 to 35 ppbv. The 
fractional increase in breath methanol due to the aspartame ingestion ranges from 3 to 6 times 
for this small cohort of healthy individuals, reaching 1470 ppbv in the breath of one 
volunteer. 
Table 1 Biometric data for the 10 healthy volunteers recruited for the study: Gender male/female; 
body weight, W; height, H; body mass index, BMI. Pre-dose, P, maximum, M, and increase, (M-P), in 
breath methanol concentrations all in ppbv (rounded to nearest 10 ppbv with uncertainties given as ±). 
 Volunteer biometrics Exhaled methanol concentrations (ppbv) 
No Gender Age W [kg] H [m] BMI P M (M-P) 
1 M 47 100 1.80 31 190±17 1310±28 1110±45 
2 F 21 80 1.67 29 340±19 1630±30 1290±49 
3 F 29 65 1.80 20 190±17 1180±27 990±44 
4 F 35 70 1.70 24 290±19 1370±29 1080±47 
5 M 23 76 1.80 24 220±17 1300±28 1080±45 
6 M 24 84 1.83 25 260±18 1730±31 1470±49 
7 F 23 52 1.62 20 390±20 1620±30 1240±50 
8 F 22 65 1.65 24 200±17 1180±27 990±44 
9 M 23 59 1.72 20 260±18 980±26 720±44 
10 M 22 76 1.77 24 440±20 1290±28 850±48 
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The increases in plasma methanol concentration due to aspartame ingestion reflect increases 
in both mouth-exhaled and nose-exhaled breath. It is instructive to compare these 
concentrations to ascertain if they are influenced by any other sources of variation. A plot of 
the nose-exhaled breath against the mouth-exhaled breath methanol concentrations obtained 
in the course of this study for various times before and after aspartame ingestion is shown in 
Figure 2. Note the close linearity of the lines with slopes of 0.87 and 0.93. This indicates that 
the nose-exhaled methanol concentration is lower than the mouth-exhaled concentration by 
about 7%. In our previous similar study involving just 3 healthy volunteers, the baseline 
nose-exhaled breath methanol was seen to be lower than the mouth-exhaled breath methanol 
variously by up to 6.5% [19]. The somewhat larger difference in the present cohort could be 
the result of small differences in nose sampling efficiency or perhaps some small methanol 
production in the oral cavity. It is also possible that the retention coefficient for methanol [33] 
is somewhat greater via the nose-breath track than via the oral cavity. Whilst the differences 
between oral and nasal concentrations are systematic, at a difference of only 7%, either 
mouth-exhaled or nose-exhaled methanol measurements can be taken as corresponding to 
systemic methanol concentrations. 
  
Figure 2 Plot of nose-exhaled against mouth-exhaled breath methanol concentration combining the 
data obtained before aspartame ingestion (● black circles) and after aspartame ingestion (○ open 
circles).  
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4. Discussion 
4.1 Pre ingestion baseline concentrations 
 
Figure 3 Box-and-whiskers plot of mouth-exhaled methanol mean concentration in ppbv obtained in 
previous SIFT-MS studies (a: Turner et al. 2006  [22], n = 30; b: Enderby et al. 2009 [24], n = 200; c: 
Spanel et al 2007 [23], n = 26, d: Cap et al. 2008 [18], n = 34) are given in the left block. The present 
mouth-exhaled methanol concentrations obtained before ingestion (P) and the maximum 
concentrations after ingestion of aspartame (M) are given in the right block. Boxes indicate 25-75 
percentile; horizontal lines indicate medians; whiskers indicate 10-90 percentile; data points (×) 
indicate minima and maxima of the ranges. 
The distribution of the mouth-exhaled breath methanol concentrations as measured pre-
ingestion of aspartame in the present study is represented by a box and whiskers plot labeled 
P in the right block in Figure 3 where it can be compared with distributions obtained in 
previous SIFT-MS studies that are shown in the left block. The median age of the present 
cohort of 10 volunteers (5 females, 5 males) is 23 years (see Table 1) and the median breath 
methanol concentration is 261 ppbv. The longitudinal (inter-individual) study by Turner et al. 
2006 [22] of mouth-exhaled methanol involved 30 healthy volunteers (11 females, 19 males, 
median age 47 years, range 24-59 years) over a period of 6 months (indicated as a in Figure 
3) indicated a median concentration of 461 ppbv [22]. The subsequent study of breath 
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methanol of 200 children in the age range 7-18 years gave a median concentration of 193 
ppbv (b) [24]), and a previous Prague study of 26 young adults age 17 to 18 years indicated a 
median mouth-exhaled methanol concentration of 238 ppbv (c) [23]). Finally, a study that 
focused on the comparison of direct exhalation methanol with volatiles released from exhaled 
breath condensate (11 males and 23 females, median age 41 years, range 25 to 62 years) 
resulted in a median exhaled methanol concentration of 189 ppbv (d) [18]).  
So there is acceptable consistency between the median values for the recent studies of cohorts 
b, c, d and P but the median value for cohort a is greater than these. Possible explanation for 
this difference is some variation in breath exhalation procedure, different volunteer age and 
the time-of-day when sampling was carried out. Dietary factors (British a, Czech d) may play 
a part, since it is generally assumed that endogenous methanol is produced by gut bacteria, so 
it is possible that higher endogenous methanol reflects an increased gut bacterial overload.  
4.2. Post aspartame ingestion concentrations 
Although each volunteer ingested an amount of aspartame according to their body weight, 
there are some differences in the maximum increases in breath methanol between the 
volunteers, as can be seen in Table 1. The observation of significant increase of the exhaled 
breath methanol concentrations as measured post-ingestion, labeled M in Figure 3, is very 
clear. Upon ingestion, the aspartame is metabolized producing the methanol, which then 
passes into the blood stream with minimal metabolic loss during the initial time frame 
involved in these studies (15 to 30 minutes) and equilibrates with total body water (TBW). 
The kinetics of equilibration between body compartments (blood, TBW) has been extensively 
investigated previously by tracing the time variation of the HDO content of exhaled breath 
following the ingestion of known amounts of D2O by cohorts of both health volunteers and 
patients with chronic kidney disease (CKD) [34]. These studies have consistently shown (by 
tracking breath HDO concentrations) that the blood stream/TBW equilibration takes only 
about 15 minutes to reach concentrations that are within about 90% of the ultimate 
equilibrium concentration, but takes 60 to 90 minutes to reach 1% of the equilibrium values 
that must be identified to accurately calculate TBW [35]. By analogy, the blood 
concentrations of methanol are within 10% of the TBW compartments concentrations of the 
individuals only about 15 minutes after aspartame ingestion. Thus, the observed methanol 
concentration reaches a peak value before appreciable metabolic loss occurs.  
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The present data reveal that the average maximum increase in mean mouth-exhaled methanol 
concentration across the cohort is 1082±205 ppbv above baseline concentrations. The 
expected increase in the breath methanol concentration can be predicted on the basis of a very 
simple one-compartment model: each ingested aspartame molecule produces one methanol 
molecule and after passing through the portal and systemic blood streams the methanol is 
uniformly dispersed into the TBW (includes the blood). On the basis of this one-compartment 
model, the breath concentration can be calculated as [36]: 
M - P = KVd/VTBW     (1) 
M is the peak breath concentration of methanol, P is the baseline breath concentration, K= 
0.177 is the dimensionless volumetric partition coefficient of methanol between blood and 
breath volume concentrations determined from the appropriate Henry’s Law coefficient (that 
happens to be identical to ethanol [37]), Vd is the volume of liquid methanol corresponding to 
the ingested dose of aspartame and VTBW is the total body water volume. If a simple estimate 
of TBW is taken as 60% of body weight of each volunteer [38], the value of (M-P) calculated 
from equation (1) is the same for all volunteers, since the ratio of the aspartame dose to TBW 
is constant, and is revealed as M-P = 1032 ppbv. This estimate is remarkably close to the 
average experimental value of 1082±205 ppbv supporting the validity of the single 
compartment model assuming that the dominant physiological process responsible for the 
initial increase in breath methanol is the dilution of the generated methanol in TBW prior to 
significant metabolic loss.  
When combined with breath ethanol measurements following ethanol ingestion, TBW/breath 
measurements have been used to study first-pass metabolism of ethanol [36] and have shown 
that small doses of ethanol are metabolized exponentially with a time constant of typically 20 
minutes, thus rapidly returning blood/breath ethanol to baseline levels in times of about 100 
minutes [39]. In contrast to this, the present results clearly indicate that the metabolism of 
methanol is relatively slow. However, it should be noted that continued endogenous 
production of methanol by gut bacteria will slow down the net methanol loss. Thus, the 
slowly decaying portions of the breath methanol curves in Figure 1 and the relatively slow 
approach to baseline (pre-dose) levels has to be seen in terms of production and loss 
processes and so we do not attempt to estimate the metabolic loss rate of the methanol 
generated from the aspartame.  
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5. Concluding remarks 
This study revealed that aspartame ingestion at the ADI dose of 40 mg/kg (2.1 to 4 g 
depending on the body weight of 10 individuals in the cohort) leads to significant increases of 
breath methanol concentration from pre-ingestion mean values ranging from 193 to 436 ppbv 
to peak values ranging from 981 to 1622 ppbv. This implies that the corresponding blood 
methanol concentrations increase 3 to 6 times above the individual baseline values. This 
study also shows that the amount of methanol formed from ingested aspartame is rapidly 
dispersed and equilibrated throughout the total body water prior to its removal by metabolism 
and can thus be accurately quantified by breath analysis.  
Methanol is present in the exhaled breath of all people largely due to colonic microbial 
production from unabsorbed complex carbohydrates. In this regard, it is interesting to note 
that it has been shown that restricting the ingestion of fruits and vegetables aimed at limiting 
potassium intake in dialysis patients effectively lowers the intake of dietary fibres, which in 
turn reduces endogenous methanol production and lowers its appearance in the exhaled 
breath [40]. Whilst the long term health effects of the increase of blood methanol 
concentrations resulting from ingestion of aspartame in addition to its endogenous production 
are not fully understood, it is important to note that it has been shown that accumulation of its 
possibly harmful metabolite formaldehyde occurs in the liver, kidneys, brain and other tissues 
[9]. 
This work is another demonstration that direct real-time analysis of even single breath 
exhalation, either via the nose or mouth, can be used to accurately determine the 
concentrations of breath trace gas metabolites, obviating sample collection into bags or onto 
traps with subsequent off-line analysis that potential complicates analysis [21]. The value of 
SIFT-MS real time analysis has also been well demonstrated by, for example, studies of 
breath ethanol and its metabolite acetaldehyde following the ingestion of alcohol [39] and by 
the TBW studies mentioned above [34, 41]. Nose/mouth exhaled breath studies can also 
distinguish between truly endogenous (systemic) compounds and those predominantly 
generated in the oral cavity, which is a necessary requirement as the topic of breath research 
progresses towards meaningful clinical diagnosis and therapeutic monitoring, as promoted 
and accelerated by the work of Professor Anton Amann to whose memory this paper is 
humbly and affectionately dedicated. 
13 
 
 
Acknowledgements 
We thank Professor Flégr for his help in obtaining ethics permission for this study and also 
the all volunteers who willingly enrolled into this study. We also thank the Czech Science 
Foundation GACR project number 13-28882S for financial support. 
 
References 
[1] Amann A and Smith D. Breath Analysis for Clinical Diagnosis and Therapeutic 
Monitoring. Singapore: World Scientific; 2005. p. 536. 
[2] Amann A and Smith D. Volatile biomarkers: Non-Invasive Diagnosis in Physiology 
and Medicine. Elsevier; 2013. 
[3] Butchko H H, Stargel W W, Comer C P, Mayhew D A, Benninger C, Blackburn G L, 
de Sonneville L M J, Geha R S, Hertelendy Z, Koestner A, Leon A S, Liepa G U, McMartin 
K E, Mendenhall C L, Munro I C, Novotny E J, Renwick A G, Schiffman S S, Schomer D L, 
Shaywitz B A, Spiers P A, Tephly T R, Thomas J A and Trefz F K 2002 Aspartame: Review 
of safety Regulatory Toxicology and Pharmacology 35 S1-S93 
[4] Dorokhov Y L, Shindyapina A V, Sheshukova E V and Komarova T V 2015 
Metabolic Methanol: Molecular Pathways and Physiological Roles Physiological Reviews 95 
603-44 
[5] Shaywitz B A, Sullivan C M, Anderson G M, Gillespie S M, Sullivan B and Shaywitz 
S E 1994 Aspartame, behavior, and cognitive function in children with attention-deficit 
disorder Pediatrics 93 70-5 
[6] Magnuson B A, Burdock G A, Doull J, Kroes R M, Marsh G M, Pariza M W, Spencer 
P S, Waddell W J, Walker R and Williams G M 2007 Aspartame: A safety evaluation based 
on current use levels, regulations, and toxicological and epidemiological studies Critical 
Reviews in Toxicology 37 629-727 
[7] Schernhammer E S, Bertrand K A, Birmann B M, Sampson L, Willett W C and 
Feskanich D 2012 Consumption of artificial sweetener- and sugar-containing soda and risk of 
lymphoma and leukemia in men and women Am. J. Clin. Nutr. 96 1419-28 
[8] Humphries P, Pretorius E and Naude H 2008 Direct and indirect cellular effects of 
aspartame on the brain Eur. J. Clin. Nutr. 62 451-62 
[9] Trocho C, Pardo R, Rafecas I, Virgili J, Remesar X, Fernandez-Lopez J and Alemany 
M 1998 Formaldehyde derived from dietary aspartame binds to tissue components in vivo 
Life sciences 63 337-49 
[10] Davoli E, Cappellini L, Airoldi L and Fanelli R 1986 Serum Methanol Concentrations 
in Rats and in Men after a Single Dose of Aspartame Food and Chemical Toxicology 24 187-
9 
[11] Sprung R, Bonte W and Lesch O M 1988 Methanol - a neglected constituent of all 
alcoholic beverages - a new biochemical approach to the problem of chronic-alcoholism 
Wiener Klinische Wochenschrift 100 282-8 
[12] Stegink L D, Brummel M C, McMartin K, Martinamat G, Filer L J, Baker G L and 
Tephly T R 1981 Blood methanol concentrations in normal adult subjects administered abuse 
doses of aspartame Journal of Toxicology and Environmental Health 7 281-90 
14 
 
[13] Stegink L D, Filer L J, Bell E F, Ziegler E E and Tephly T R 1989 Effect of Repeated 
Ingestion of Aspartame-Sweetened Beverage on Plasma Amino-Acid, Blood Methanol, and 
Blood Formate Concentrations in Normal Adults Metabolism-Clinical and Experimental 38 
357-63 
[14] Eriksen S P 1963 Methanol in normal human breath Science 141 639 
[15] Taucher J, Lagg A, Hansel A, Vogel W and Lindinger W 1995 Methanol in Human 
Breath Alcoholism: Clinical and Experimental Research 19 1147-50 
[16] Lindinger W, Taucher J, Jordan A, Hansel A and Vogel W 1997 Endogenous 
production of methanol after the consumption of fruit Alcoholism: Clinical and Experimental 
Research 21 939-43 
[17] Fenske J D and Paulson S E 1999 Human breath emissions of VOCs Journal of the 
Air & Waste Management Association 49 594-8 
[18] Cap P, Dryahina K, Pehal F and Španěl P 2008 Selected ion flow tube mass 
spectrometry of exhaled breath condensate headspace Rapid Commun. Mass Spectrom. 22 
2844-50 
[19] Wang T S, Pysanenko A, Dryahina K, Španěl P and Smith D 2008 Analysis of breath, 
exhaled via the mouth and nose, and the air in the oral cavity J. Breath Res. 2 037013 
[20] Michalčíková R B and Španěl P 2014 A selected ion flow tube study of the ion 
molecule association reactions of protonated (MH+), nitrosonated (MNO+) and 
dehydroxidated (M-OH)(+) carboxylic acids (M) with H2O Int. J. Mass Spectrom. 368 15-22 
[21] Smith D and Španěl P 2015 Pitfalls in the analysis of volatile breath biomarkers; 
suggested solutions and SIFT-MS quantification of single metabolites J. Breath Res. 9 
022001 
[22] Turner C, Španěl P and Smith D 2006 A longitudinal study of methanol in the exhaled 
breath of 30 healthy volunteers using selected ion flow tube mass spectrometry, SIFT-MS 
Physiol. Meas. 27 637-48 
[23] Španěl P, Dryahina K and Smith D 2007 The concentration distributions of some 
metabolites in the exhaled breath of young adults J. Breath Res. 1 026001 
[24] Enderby B, Lenney W, Brady M, Emmett C, Španěl P and Smith D 2009 
Concentrations of some metabolites in the breath of healthy children aged 7-18 years 
measured using selected ion flow tube mass spectrometry (SIFT-MS) J. Breath Res. 3 
036001 
[25] EFSA ANS Panel (EFSA Panel on Food Additives and Nutrient Sources added to 
food) 2013 Scientific Opinion on the re-evaluation of aspartame (E 951) as a food additive 
EFSA Journal 11 3496 
[26] Španěl P and Smith D 2011 Progress in SIFT-MS: Breath analysis and other 
applications Mass Spectrom. Rev. 30 236-67 
[27] Smith D and Španěl P 2005 Selected ion flow tube mass spectrometry (SIFT-MS) for 
on-line trace gas analysis Mass Spectrom. Rev. 24 661-700 
[28] Smith D and Španěl P 2011 Ambient analysis of trace compounds in gaseous media 
by SIFT-MS Analyst 136 2009-32 
[29] Smith D and Španěl P 2013 On the features, successes and challenges of selected ion 
flow tube mass spectrometry, SIFT-MS Eur. J. Mass Spectrom. 19 225–46 
[30] Španěl P and Smith D 2013 Advances in On-line Absolute Trace Gas Analysis by 
SIFT-MS Curr. Anal. Chem. 9 525-39 
[31] Španěl P, Dryahina K and Smith D 2006 A general method for the calculation of 
absolute trace gas concentrations in air and breath from selected ion flow tube mass 
spectrometry data Int. J. Mass Spectrom. 249 230-9 
15 
 
[32] Španěl P and Smith D 2001 On-line measurement of the absolute humidity of air, 
breath and liquid headspace samples by selected ion flow tube mass spectrometry Rapid 
Commun. Mass Spectrom. 15 563-9 
[33] Španěl P, Dryahina K and Smith D 2013 A quantitative study of the influence of 
inhaled compounds on their concentrations in exhaled breath J. Breath Res. 7 017106 
[34] Davies S J, Španěl P and Smith D 2014 Breath analysis of ammonia, volatile organic 
compounds and deuterated water vapor in chronic kidney disease and during dialysis 
Bioanalysis 6 843-57 
[35] Smith D and Španěl P 2001 On-line determination of the deuterium abundance in 
breath water vapour by flowing afterglow mass spectrometry with applications to 
measurements of total body water Rapid Commun. Mass Spectrom. 15 25-32 
[36] Wang T S, Španěl P and Smith D 2005 The combined use of SIFT-MS and FA-MS to 
investigate first-pass metabolism of ethanol. In: Amann A, Smith D, eds. Breath Analysis: for 
Clinical Diagnosis and ATherapeutic Monitoring Singapore: World Scientific Publ Co Pte 
Ltd) p. 479-90. 
[37] Sander R 1999 Compilation of Henry's Law constants for inorganic and organic 
species of potential importance in environmental chemistry Mainz: Max-Planck Institute of 
Chemistry) 
[38] Davies S J, Španěl P and Smith D 2001 Rapid measurement of deuterium content of 
breath following oral ingestion to determine body water Physiol. Meas. 22 651-9 
[39] Smith D, Wang T S and Španěl P 2002 On-line, simultaneous quantification of 
ethanol, some metabolites and water vapour in breath following the ingestion of alcohol 
Physiol. Meas. 23 477-89 
[40] Lee H J, Pahl M V, Vaziri N D and Blake D R 2012 Effect of Hemodialysis and Diet 
on the Exhaled Breath Methanol Concentration in Patients With ESRD Journal of Renal 
Nutrition 22 357-64 
[41] Chan C, Smith D, Španěl P, McIntyre C W and Davies S J 2008 A non-invasive, on-
line deuterium dilution technique for the measurement of total body water in haemodialysis 
patients Nephrol. Dial. Transplant. 23 2064-70 
 
